Clinical Trial Update: Evaluation of a Pharmacogenetic-based Warfarin Dosing Algorithm in Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating a pharmacogenetic-based warfarin dosing algorithm in patients with atrial fibrillation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Snippet

Sponsor: University of Sao Paulo General Hospital | Conditions: Atrial Fibrillation | Phase 4 | Status: UNKNOWN